A patient who has experienced preterm births with her previous two pregnancies will begin receiving hydroxyprogesterone caproate [Makena] to prevent preterm delivery with her current pregnancy. Which statement by the patient indicates a need for further teaching about this drug?
A) "I should report any calf pain immediately."
B) "I will eventually learn to administer the injections of this drug myself."
C) "This drug may cause fluid retention and glucose intolerance."
D) "This medication must be given once a week until 37 weeks' gestation."

Question

Quizplus · Accepted Answer

Hydroxyprogesterone caproate is given IM and must be given by a healthcare provider and not by the patient. Although serious side effects are rare, thrombosis and thromboembolism may occur, so the patient should report signs of thrombosis immediately. Fluid retention and glucose intolerance may occur. The medication is given weekly from 16 to 21 weeks' gestation up to 37 weeks or delivery of the baby.

A Patient Who Has Experienced Preterm Births with Her Previous